Stada Arzneimittel AG | Income Statement
Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,004
2,062
2,115
2,139
2,314
2,331
Cost of Goods Sold (COGS) incl. D&A
1,045
1,091
1,119
1,122
1,194
1,156
Gross Income
959
972
996
1,018
1,120
1,175
SG&A Expense
692
652
718
726
803
783
EBIT
-
320
278
292
317
392
Unusual Expense
17
104
36
66
46
16
Non Operating Income/Expense
14
26
22
50
79
-
Interest Expense
68
68
65
51
49
42
Pretax Income
186
123
156
127
145
339
Income Tax
66
55
41
32
53
32
Equity in Affiliates
4
2
1
1
2
4
Consolidated Net Income
123
70
117
95
95
311
Net Income
121
65
110
86
85
307
Net Income After Extraordinaries
121
65
110
86
85
307
Net Income Available to Common
121
65
110
86
85
307
EPS (Basic)
2.04
1.07
1.79
1.38
1.37
4.93
Basic Shares Outstanding
60
60
62
62
62
62
EPS (Diluted)
2.00
1.05
1.79
1.38
1.37
4.93
Diluted Shares Outstanding
61
61
62
62
62
62
EBITDA
326
441
397
409
439
514
Other Operating Expense
48
-
-
-
-
-
Non-Operating Interest Income
4
1
1
3
4
6
Minority Interest Expense
1
6
7
10
9
4
About Stada Arzneimittel
View Profile
